
N6-methyladenosine in DNA promotes genome stability
Single-cell imaging and mass spectrometry data reveal adenosine in the DNA of mammalian cells can be methylated by METTL3 to form N6-methyladenosine in response to DNA damage.
eLifeLoss of
#METTL3, and the resulting changes in m6A modifications, leads to enhanced
#brain infiltration of monocyte-derived
#macrophages in a mouse model of
#AlzheimersDisease, promoting Aβ clearance and improving pathology & cognitive decline
#PLOSBiology https://plos.io/3F1ClcQ
Loss of the m6A methyltransferase METTL3 in monocyte-derived macrophages ameliorates Alzheimer’s disease pathology in mice
This study reveals that loss of METTL3, and the corresponding changes in m6A modifications, leads to enhanced brain infiltration of monocyte-derived macrophages in a mouse model of Alzheimer’s Disease, promoting Aβ clearance and ameliorating pathology and cognitive decline.
Loss of
#METTL3, and the resulting changes in m6A modifications, leads to enhanced
#brain infiltration of monocyte-derived
#macrophages in a mouse model of
#AlzheimersDisease, promoting Aβ clearance and improving pathology & cognitive decline
#PLOSBiology https://plos.io/3F1ClcQ
Loss of the m6A methyltransferase METTL3 in monocyte-derived macrophages ameliorates Alzheimer’s disease pathology in mice
This study reveals that loss of METTL3, and the corresponding changes in m6A modifications, leads to enhanced brain infiltration of monocyte-derived macrophages in a mouse model of Alzheimer’s Disease, promoting Aβ clearance and ameliorating pathology and cognitive decline.
Loss of
#METTL3, and the resulting changes in m6A modifications, leads to enhanced
#brain infiltration of monocyte-derived
#macrophages in a mouse model of
#AlzheimersDisease, promoting Aβ clearance and improving pathology & cognitive decline
#PLOSBiology https://plos.io/3F1ClcQ
Loss of the m6A methyltransferase METTL3 in monocyte-derived macrophages ameliorates Alzheimer’s disease pathology in mice
This study reveals that loss of METTL3, and the corresponding changes in m6A modifications, leads to enhanced brain infiltration of monocyte-derived macrophages in a mouse model of Alzheimer’s Disease, promoting Aβ clearance and ameliorating pathology and cognitive decline.